CLASS II ONGOING Device recall · Reported 21 Dec 2022 · FDA Enforcement Report

DeRoyal Myelogram Pack recalled by DeRoyal Industries

DeRoyal Industries is recalling DeRoyal Myelogram Pack, distributed in 23 states. The recall was initiated on 3 Nov 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Numbers: Lot 55612944 exp 3/1/2026; Lot 56615881 exp 7/1/2026; Lot 56279557 exp 5/1/2026; Lot 57185350 exp7/1/2026; Lot 57591593 exp 1/1/2025
Quantity recalled2280 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0647-2023
FDA event ID
91134
Recalling firm
DeRoyal Industries, Powell, TN
Classification
Class II
Status
Ongoing
Recall initiated
3 Nov 2022
FDA classified
15 Dec 2022
Reported
21 Dec 2022
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Other Reasons

Timeline

3 Nov 2022Recall initiated by company
15 Dec 2022Classified by FDA+42 days
21 Dec 2022Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

XXX

Product as listed by the FDA

DeRoyal MYELOGRAM PACK, REF 89-9304.05

Where it was distributed

US: Tennessee, Texas, New York, Wisconsin, Florida, Virginia, Massachusetts, Arizona, Missouri, Connecticut, New Jersey, Pennsylvania, North Carolina, Louisiana, Michigan, Minnesota, Ohio, Indiana, Kansas, Illinois, Alabama, Georgia, Mississippi

AlabamaArizonaConnecticutFloridaGeorgiaIllinoisIndianaKansasLouisianaMassachusettsMichiganMinnesotaMissouriMississippiNorth CarolinaNew JerseyNew YorkOhioPennsylvaniaTennessee

Questions about this recall

Is DeRoyal Myelogram Pack recalled?

Yes. DeRoyal Industries recalled DeRoyal Myelogram Pack on 3 Nov 2022. The recall is Class II and its status is Ongoing. Recall number Z-0647-2023.

Why was it recalled?

XXX

Which lots are affected?

Lot Numbers: Lot 55612944 exp 3/1/2026; Lot 56615881 exp 7/1/2026; Lot 56279557 exp 5/1/2026; Lot 57185350 exp7/1/2026; Lot 57591593 exp 1/1/2025

Where was it sold?

US: Tennessee, Texas, New York, Wisconsin, Florida, Virginia, Massachusetts, Arizona, Missouri, Connecticut, New Jersey, Pennsylvania, North Carolina, Louisiana, Michigan, Minnesota, Ohio, Indiana, Kansas, Illinois, Alabama, Georgia, Mississippi

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from DeRoyal Industries

All 226

Other Other Medical Devices recalls

All 13,778